Cellectis (CLLS) Share-based Compensation (2015 - 2026)

Cellectis' Share-based Compensation history runs 12 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 70.39% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $6.8 million, a 108.75% increase from a year earlier, with the FY2025 full-year figure at $6.1 million, up 92.93% from the prior year.
• Share-based Compensation slipped to $1.7 million in Q1 2026 per CLLS's latest filing, from $2.2 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $10.0 million in Q3 2022 and bottomed at -$6.6 million in Q2 2022.
• The 5-year median for Share-based Compensation is $1.3 million (2025), against an average of $1.3 million.
• Biggest YoY gain for Share-based Compensation was 7620.0% in 2022; the steepest drop was 266.49% in 2022.
• Year by year, Share-based Compensation stood at $387000.0 in 2022, then jumped by 1094.06% to $4.6 million in 2023, then slumped by 80.87% to $884000.0 in 2024, then surged by 154.52% to $2.2 million in 2025, then retreated by 26.09% to $1.7 million in 2026.
• Per Business Quant, the three latest CLLS Share-based Compensation figures stand at $1.7 million (Q1 2026), $2.2 million (Q4 2025), and $1.6 million (Q3 2025).